Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_provenance.
- NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_assertion description "[Molecular therapeutic approaches, for example, those directed against the fusion protein BCR-ABL with ABL-tyrosine kinase inhibitor, are on the way to creating a new avenue for the treatment of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_provenance.
- NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_assertion evidence source_evidence_literature NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_provenance.
- NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_assertion SIO_000772 11049022 NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_provenance.
- NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_assertion wasDerivedFrom befree-2016 NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_provenance.
- NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_assertion wasGeneratedBy ECO_0000203 NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_provenance.
- befree-2016 importedOn "2016-02-19" NP298419.RA5TGYVwC0JewhZ5A2300yt5UpCBZhwCZnSnKQi5FPDG4130_provenance.